Profile data is unavailable for this security.
About the company
Beijing Konruns Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of drugs. The Company's main product Suling belongs to the haemocoagulase drug that activates the coagulation process, which is mainly used for hemostasis of superficial wound bleeding in surgical operations as well as the bleeding caused by postoperative, trauma and disease. The Company’s present products under research include a range of innovative and generic drugs for tumors and blood. The Company mainly distributes its products in the domestic market.
- Revenue in CNY (TTM)954.14m
- Net income in CNY166.44m
- Incorporated2003
- Employees447.00
- LocationBeijing Konruns Pharmaceutical Co LtdNo. 3 Building, No. 7 YardKexueyuan Road, Zhongguancun LifeScience Park, Changping DistrictBEIJING 102206ChinaCHN
- Phone+86 1 082898898
- Fax+86 1 082898886
- Websitehttp://www.konruns.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hangzhou Alltest Biotech Co Ltd | 718.48m | 184.83m | 4.70bn | 1.09k | 25.44 | 1.20 | -- | 6.53 | 2.33 | 2.33 | 9.02 | 49.43 | 0.165 | 2.13 | 6.17 | 657,349.00 | 4.24 | 23.35 | 4.57 | 26.83 | 46.83 | 58.34 | 25.69 | 39.07 | 10.16 | -- | 0.0056 | 29.79 | -77.73 | 32.59 | -84.75 | 26.19 | 72.77 | -- |
GemPharmatech Co Ltd | 638.97m | 157.34m | 4.71bn | 1.51k | 29.91 | 2.21 | -- | 7.37 | 0.3838 | 0.3838 | 1.56 | 5.20 | 0.2617 | 4.11 | 2.36 | 424,282.40 | 6.44 | 9.45 | 7.28 | 11.13 | 66.43 | 70.21 | 24.62 | 28.16 | 4.68 | -- | 0.0592 | 14.68 | 20.45 | 63.48 | -3.48 | -- | 141.38 | -- |
Hainan Huluwa Pharmaceutical Grop Co Ltd | 1.81bn | 94.97m | 4.72bn | 2.47k | 49.71 | 4.11 | -- | 2.61 | 0.2374 | 0.2374 | 4.52 | 2.87 | 0.6721 | 2.88 | 3.81 | 732,708.90 | 3.80 | 5.81 | 6.29 | 9.78 | 50.33 | 58.01 | 5.66 | 7.03 | 0.8245 | 7.04 | 0.5246 | 21.74 | 25.75 | 14.13 | 24.29 | 1.16 | 46.37 | -- |
Yabao Pharmaceutical Group Co Ltd | 2.88bn | 204.43m | 4.74bn | 4.14k | 23.89 | 1.62 | -- | 1.64 | 0.2754 | 0.2754 | 3.81 | 4.05 | 0.7193 | 2.98 | 6.79 | 695,432.10 | 4.52 | 2.82 | 5.90 | 3.97 | 56.00 | 59.20 | 6.29 | 4.19 | 1.62 | 47.13 | 0.0675 | 43.74 | 7.05 | -0.0572 | 90.71 | -6.10 | 7.98 | -9.71 |
Shanghai Haoyuan Chemexpress Co Ltd | 1.97bn | 97.97m | 4.76bn | 3.37k | 48.54 | 1.87 | -- | 2.42 | 0.652 | 0.652 | 13.10 | 16.92 | 0.4845 | 1.01 | 3.91 | 583,547.80 | 2.38 | 7.38 | 3.23 | 9.60 | 42.51 | 47.03 | 4.92 | 13.53 | 0.894 | 3.37 | 0.3013 | 14.37 | 38.44 | 44.33 | -34.18 | 47.24 | 48.95 | -- |
Shanghai Medicilon Inc | 1.17bn | -172.33m | 4.77bn | 2.60k | -- | 1.93 | -- | 4.07 | -1.24 | -1.24 | 9.11 | 18.34 | 0.4205 | 6.63 | 1.64 | 451,437.20 | -6.17 | 9.34 | -7.97 | 11.73 | 12.48 | 36.71 | -14.68 | 14.93 | 2.63 | -- | 0.1229 | 20.18 | -17.68 | 33.26 | -109.82 | -- | 23.60 | -- |
Getein Biotech Inc | 1.31bn | 244.26m | 4.81bn | 2.14k | 19.68 | 1.82 | -- | 3.68 | 0.4816 | 0.4816 | 2.58 | 5.22 | 0.3502 | 1.61 | 2.77 | 611,337.70 | 6.63 | 13.25 | 9.24 | 18.45 | 66.13 | 65.57 | 18.92 | 28.13 | 1.97 | -- | 0.1857 | 29.88 | -24.85 | 14.81 | -43.92 | 2.31 | 18.44 | 6.00 |
Beijing Konruns Pharmaceutical Co Ltd | 954.14m | 166.44m | 4.83bn | 447.00 | 28.48 | 1.53 | -- | 5.06 | 1.06 | 1.06 | 6.05 | 19.78 | 0.2548 | 2.50 | 3.73 | 2,134,547.00 | 5.46 | 5.43 | 6.39 | 6.24 | 88.29 | 89.93 | 21.44 | 20.76 | 3.08 | -- | 0.0486 | 21.53 | 6.15 | -2.08 | 48.24 | -10.63 | 43.05 | -9.71 |
Data as of May 17 2024. Currency figures normalised to Beijing Konruns Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
CITIC Securities Co., Ltd. (Invt Port)as of 30 Jun 2023 | 2.84m | 1.77% |
China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 1.55m | 0.97% |
Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2023 | 1.27m | 0.79% |
Penghua Fund Management Co., Ltd.as of 30 Jun 2023 | 1.04m | 0.65% |
China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 909.79k | 0.57% |
Fullgoal Fund Management Co., Ltd.as of 30 Jun 2023 | 519.30k | 0.33% |
HFT Investment Management Co., Ltd.as of 30 Jun 2023 | 509.55k | 0.32% |
HuaAn Fund Management Co., Ltd.as of 30 Jun 2023 | 298.90k | 0.19% |
Nuode Asset Management Co., Ltd.as of 30 Jun 2023 | 290.42k | 0.18% |
Harvest Fund Management Co., Ltd.as of 30 Jun 2023 | 123.10k | 0.08% |
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.